Docs
All documentation Fundamental API Live (Delayed) API EOD Historical API Intraday API Real-Time (websockets) API Google Sheets add-on Excel add-on
Community
Academy 134 articles Forum Github 13 repos
Marketplace
Spreadsheets
Google Sheets add-on Excel add-on Wordpress plugin
Pricing
Overview Fundamentals API Earnings EOD API Sample Code Pricing
Register now
Free trial

No credit cards required

Get free API key
  1. Supported exchanges /
  2. NASDAQ /
  3. GERN.NASDAQ

Geron Corporation (GERN NASDAQ) stock market data APIs

$4.35 -0.31(-6.7%) as of July 26, 2024
Price chart is built with Anychart

Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in myeloid hematologic malignancies for the treatment of low or intermediate-1 risk myelodysplastic syndromes and intermediate-2 or high-risk myelofibrosis. The company was incorporated in 1990 and is headquartered in Foster City, California.

Geron Corporation Financial Data Overview

4.66
4.35
-
4.77
4.35
1.64-5.34
2 545 M
593 M
520 K
-0.09
0.477
Our easy-to-use no-coding solutions help you get the data effortlessly:
Excel Financial Add-In Google Sheets Financial Add-In Python
APIs SDK Windows Downloader

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: 'GERN',
Type: 'Common Stock',
Name: 'Geron Corporation',
Exchange: 'NASDAQ',
CurrencyCode: 'USD',
CurrencyName: 'US Dollar',
CurrencySymbol: '$',
CountryName: 'USA',
CountryISO: 'US',
OpenFigi: 'BBG000GX1891',
ISIN: NULL,
CUSIP: NULL,
CIK: '886744',
EmployerIdNumber: '75-2287752',
FiscalYearEnd: 'December',
IPODate: '1996-06-30',
InternationalDomestic: 'Domestic',
Sector: 'Healthcare',
Industry: 'Biotechnology',
HomeCategory: 'Domestic',
IsDelisted: false,
}

Geron Corporation Fundamental Data is available in our Financial Data APIs

  • Net Revenue 520 K
  • EBITDA -209 532 000
  • Earnings Per Share -0.34
  • Income Statements
  • Balance Sheets
  • Cash flows
Fundamental data package from $59.99 See full price
Get sample
of Fundamental API Data

Get Geron Corporation Earnings via APIs

  • Latest Release 2024-05-02
  • EPS/Forecast -0.1

Get Geron Corporation End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends

Get Geron Corporation latest news via APIs

Geron Corporation Announces Chief Commercial Officer to Depart at End of August 2024

FOSTER CITY, Calif., July 23, 2024--(BUSINESS WIRE)--Geron Corporation (Nasdaq: GERN), a commercial-stage biopharmaceutical company aiming to change lives by changing the course of blood cancer, today...

Geron (GERN) to Report Q2 Earnings: What's in the Cards?

Geron GERN is slated to report second-quarter 2024 results on Aug 8, before the opening bell. GERN is a clinical-stage company that focuses on developing novel therapies to treat patients living with...
Do you have any questions?
support@eodhistoricaldata.com